查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1978302

全球可生物降解支架市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Biodegradable Stents Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 135 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2034 年，可生物降解支架市场规模将从 2025 年的 4.367 亿美元成长至 8.9577 亿美元，2026 年至 2034 年的复合年增长率为 8.31%。

随着心血管治疗医疗技术的进步，全球可降解支架市场正迅速成长。可降解支架旨在暂时支撑阻塞的动脉，并在动脉癒合后逐渐被人体吸收。这减少了与传统金属支架相关的长期併发症，并改善了患者的復原效果。

心血管疾病发生率的上升是市场成长的主要驱动力。生活方式的改变、人口老化以及冠状动脉疾病病例的增加，都导致心臟介入治疗的需求增加。医疗机构正在采用可生物降解支架，因为它们可以提高安全性，并使部分患者无需植入永久性植入。

展望未来，随着生物材料和医疗设备技术研究的不断深入，市场预计将持续扩张。製造商正在研发具有卓越强度和可控降解特性的先进生物降解材料。随着微创心血管治疗的日益普及，生物降解支架将在现代心臟病治疗中发挥至关重要的作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球可生物分解支架市场：依支架类型划分

  • 市场分析、洞察与预测
  • 冠状动脉支架
  • 週边动脉支架

第五章 全球可生物分解支架市场：依材料类型划分

  • 市场分析、洞察与预测
  • 聚合物基
  • 金属底座

第六章 全球可生物分解支架市场：依最终用户划分

  • 市场分析、洞察与预测
  • 医院
  • 心臟导管检查室
  • 门诊手术中心

第七章 全球可生物分解支架市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Boston Scientific
    • Abbott
    • Elixir Medical Corporation
    • Kyoto Medical Planning Co. Ltd
    • Biotronik
    • Terumo Corporation
    • Medtronic Plc
    • B. Braun Melsungen AG
    • Arterial Remodeling Technologies SA
    • Amaranth Medical Inc
简介目录
Product Code: VMR112114534

The Biodegradable Stents Market size is expected to reach USD 895.77 Million in 2034 from USD 436.70 Million (2025) growing at a CAGR of 8.31% during 2026-2034.

The global biodegradable stents market is growing rapidly as medical technology advances in cardiovascular treatments. Biodegradable stents are designed to temporarily support blocked arteries and gradually dissolve in the body after the artery heals. This reduces the long-term complications associated with traditional metal stents and improves patient recovery outcomes.

The increasing prevalence of cardiovascular diseases is a major driver of market growth. Lifestyle changes, aging populations, and rising cases of coronary artery disease are leading to more interventional cardiology procedures. Healthcare providers are adopting biodegradable stents as they offer improved safety and eliminate the need for permanent implants in some patients.

Looking ahead, the market is expected to expand as research in biomaterials and medical device technology continues to progress. Manufacturers are developing advanced biodegradable materials that provide better strength and controlled degradation. As minimally invasive cardiovascular procedures become more common, biodegradable stents will play a key role in modern heart disease treatments.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Stent Type

  • Coronary Artery Stents
  • Peripheral Artery Stents

By Material Type

  • Polymer-based
  • Metal-based

By End-user

  • Hospitals
  • Cardiac Catheterization Laboratories
  • Ambulatory Surgery Centers

COMPANIES PROFILED

  • Boston Scientific, Abbott, Elixir Medical Corporation, Kyoto Medical Planning Co Ltd, Biotronik, Terumo Corporation, Medtronic Plc, B Braun Melsungen AG, Arterial Remodeling Technologies SA, Amaranth Medical Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIODEGRADABLE STENTS MARKET: BY STENT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Stent Type
  • 4.2. Coronary Artery Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Peripheral Artery Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIODEGRADABLE STENTS MARKET: BY MATERIAL TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Material Type
  • 5.2. Polymer-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Metal-based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIODEGRADABLE STENTS MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Cardiac Catheterization Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Ambulatory Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIODEGRADABLE STENTS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Stent Type
    • 7.2.2 By Material Type
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Stent Type
    • 7.3.2 By Material Type
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Stent Type
    • 7.4.2 By Material Type
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Stent Type
    • 7.5.2 By Material Type
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Stent Type
    • 7.6.2 By Material Type
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIODEGRADABLE STENTS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Boston Scientific
    • 9.2.2 Abbott
    • 9.2.3 Elixir Medical Corporation
    • 9.2.4 Kyoto Medical Planning Co. Ltd
    • 9.2.5 Biotronik
    • 9.2.6 Terumo Corporation
    • 9.2.7 Medtronic Plc
    • 9.2.8 B. Braun Melsungen AG
    • 9.2.9 Arterial Remodeling Technologies SA
    • 9.2.10 Amaranth Medical Inc